Principle Research Scientist in Bioinformatics. After receiving his B.S. in Chemistry with a Computer Science option from the University of Pittsburgh in 1988, Dr. Dow joined Eli Lilly and Company focusing on computational chemistry. Following an AI Fellowship with Digital Equipment Corporation in neural networks he worked on QSAR and then took an educational leave, obtaining his Ph.D. from the University of Illinois at Urbana-Champaign in Biophysics and Computational Biology under Dr. Thomas Anastasio in 1999. He has been in Bioinformatics leading the effort to gain insight into biology from microarray and other high information content studies.